NORMAL MPTP BINDING IN PARKINSONIAN SUBSTANTIA NIGRA: EVIDENCE FOR EXTRANEURONAL TOXIN CONVERSION IN HUMAN BRAIN
- 27 April 1985
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 325 (8435), 956-957
- https://doi.org/10.1016/s0140-6736(85)91729-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Brain Enzyme Is the Target of Drug ToxinScience, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain.Proceedings of the National Academy of Sciences of the United States of America, 1984
- Quantitative autoradiography of [3H]MPTP binding sites in rat brainEuropean Journal of Pharmacology, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences of the United States of America, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.Proceedings of the National Academy of Sciences of the United States of America, 1982
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979